SCHEMBL29353719

SCHEMBL29353719

O=C1C(c2[nH]c3ccccc3c2O)=Nc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 4/20 1.00
ALDH1A1 P00352 4/20 1.00
CCNE1 P24864 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
SRC P12931 2/20 1.00
CTRB1 P17538 2/20 1.00
AHR P35869 2/20 1.00
RECQL P46063 1/20 1.00
HSD17B10 Q99714 1/20 1.00
GSK3A P49840 12/20 0.70
GSK3B P49841 12/20 0.70
CDK5 Q00535 9/20 0.70
CDK5R1 Q15078 9/20 0.70
CDK1 P06493 6/20 0.70
CCNB2 O95067 5/20 0.70
CCNB1 P14635 5/20 0.70
CCNB3 Q8WWL7 5/20 0.70
MAPT P10636 4/20 0.70
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23064865 1.00 CDK2 (1.00) CDK2ALDH1A1CCNE1TDP1SRC
SCHEMBL29421607 0.82 GSK3A (1.00) CDK2ALDH1A1CCNE1TDP1SRC
SCHEMBL30897991 0.82 FLT3 (0.74) CDK2ALDH1A1CCNE1TDP1SRC
SCHEMBL21316073 0.74 MEN1 (0.63) CDK2ALDH1A1CCNE1TDP1SRC
Indoxyl Red SCHEMBL30636774 0.74 S100A4 (0.71) CDK2ALDH1A1CCNE1TDP1SRC
Indoxyl Red SCHEMBL22890564 0.74 S100A4 (0.71) CDK2ALDH1A1CCNE1TDP1SRC
SCHEMBL29440652 0.73 GSK3B (0.71) CDK2ALDH1A1CCNE1TDP1SRC
SCHEMBL29364210 0.73 GSK3A (0.71) CDK2ALDH1A1CCNE1TDP1SRC
SCHEMBL29459757 0.72 ALDH1A1 (1.00) CDK2ALDH1A1CCNE1TDP1SRC
SCHEMBL28894653 0.71 MAPT (0.61) CDK2ALDH1A1CCNE1TDP1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4745571-A1 METHOD FOR ASSESSING DISORDER OF MUCOUS MEMBRANE OF GASTROINTESTINAL TRACT SHIMADZU CORPORATION (JP) 2026-05-20 EP claimed
EP-3683262-B2 THERMOPLASTIC ELASTOMER COMPOSITION, FOAM PARTICLE, AND FOAM MOLDED BODY SEKISUI PLASTICS (JP) 2025-10-15 EP claimed
EP-4058075-B1 FIBER REINFORCED COMPOSITIONS AND METHODS OF MANUFACTURE FOR MEDICAL DEVICE APPLICATIONS EVONIK OPERATIONS GMBH (DE) 2025-08-20 EP claimed
EP-4511077-A1 BONE REPAIR COMPOSITIONS COMPRISING POLYTHIOURETHANE AND USES THEREOF Smith&Nephew, Inc. (US) 2025-02-26 EP claimed
WO-2025013850-A1 METHOD FOR ASSESSING DISORDER OF MUCOUS MEMBRANE OF GASTROINTESTINAL TRACT 株式会社島津製作所 2025-01-16 WO claimed
US-12163020-B2 Biodegradable polymer blends for manufacturing medical devices EVONIK OPERATIONS GMBH (DE) 2024-12-10 US claimed
CN-112789549-B Visibility control equipment 纳米与软物质科学中心 2024-11-12 CN claimed
EP-3583644-B1 ELECTRODE MATERIALS AND PROCESSES FOR THEIR PREPARATION HYDRO QUEBEC (CA) 2024-08-07 EP claimed
WO-2023205141-A1 BONE REPAIR COMPOSITIONS COMPRISING POLYTHIOURETHANE AND USES THEREOF SMITH & NEPHEW, INC. (US) 2023-10-26 WO claimed
US-11744794-B2 Indigo darkener and hair dyeing process SONG ZIKUI (CN) 2023-09-05 US claimed
US-20220409778-A1 FIBER REINFORCED COMPOSITIONS AND METHODS OF MANUFACTURE FOR MEDICAL DEVICE APPLICATIONS EVONIK OPERATIONS GMBH (DE) 2022-12-29 US claimed
US-20220401351-A1 INDIGO DARKENER AND HAIR DYEING PROCESS SONG ZIKUI (CN) 2022-12-22 US claimed
EP-4058075-A1 FIBER REINFORCED COMPOSITIONS AND METHODS OF MANUFACTURE FOR MEDICAL DEVICE APPLICATIONS Evonik Operations GmbH (DE) 2022-09-21 EP claimed
US-12638614-B2 Method for making silicone hydrogel contact lenses ALCON INC. (CH) 2026-05-26 US disclosed
EP-4745571-A1 METHOD FOR ASSESSING DISORDER OF MUCOUS MEMBRANE OF GASTROINTESTINAL TRACT SHIMADZU CORPORATION (JP) 2026-05-20 EP disclosed
US-12629345-B2 Methods, compositions, and devices for drug / live cell microarrays PATHAK HOLDINGS LLC (US) 2026-05-19 US disclosed
US-20220043333-A1 PHOTORESPONSIVE COMPOUND Konica Minolta, Inc. (JP) 2022-02-10 US disclosed
US-20220040980-A1 METHOD FOR CLEANING INK DISCHARGER OF INKJET HEAD Konica Minolta, Inc. (JP) 2022-02-10 US disclosed
EP-3762238-B1 INKJET PRE-TREATMENT FLUID FOR TEXTILE PRINTING HEWLETT PACKARD DEVELOPMENT CO (US) 2022-01-26 EP disclosed
US-11229584-B2 Pigment dispersion liquid for cosmetics, and aqueous liquid cosmetic using same MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2022-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12629345-B2 Methods, compositions, and devices for drug / live cell microarrays SRMS, FKBP4, MYL4 CDK2 3592/4885ALDH1A1 2168/4885CCNE1 2235/4885
US-12638614-B2 Method for making silicone hydrogel contact lenses SMCHD1, CRYAA, CRYZ CDK2 1740/4885ALDH1A1 2364/4885CCNE1 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.